Notes to the financial statements

 

1. SUMMARY OF ACCOUNTING POLICIES
2. CRITICAL ACCOUNTING ESTIMATES AND ASSUMPTIONS
3. FINANCIAL RISK MANAGEMENT
4. SEGMENT INFORMATION
5. PROPERTY AND EQUIPMENT
6. INVESTMENT PROPERTY
7. INTANGIBLE ASSETS
8. FINANCIAL INSTRUMENTS
9. INVESTMENTS IN ASSOCIATES
10. INVESTMENTS IN SUBSIDIARIES
11. DEFERRED TAX
12. INVENTORY
13. OTHER INVESTMENTS
14. ISSUED CAPITAL
15. OTHER RESERVES
16. NON-CONTROLLING INTEREST
17. LEASES
18. EMPLOYMENT BENEFIT LIABILITY
19. REVENUE
20. COST OF PHARMACEUTICAL PRODUCTS AND FINISHED GOODS
21. PROFIT BEFORE TAXATION
22. NET FINANCE COSTS
23. INCOME TAX EXPENSE
24. EARNINGS PER SHARE
25. CASH FLOWS FROM OPERATING ACTIVITIES
26. INCOME TAX PAID
27. DIVIDENDS
28. SHARE-BASED PAYMENTS
29. CONTINGENCIES, COMMITMENTS AND GUARANTEES
30. RELATED PARTY TRANSACTIONS
31. PENSIONS AND OTHER RETIREMENT OBLIGATIONS
32. DEFERRED PAYMENT
33. SUBSEQUENT EVENTS
34. IMPACT OF COVID-19 AND GOING CONCERN
35. RESTATEMENT OF JUNE 2019 RESULTS